Not available
Quote | Emergent Biosolutions Inc. (NYSE:EBS)
Last: | $2.53 |
---|---|
Change Percent: | -0.77% |
Open: | $2.61 |
Close: | $2.53 |
High: | $2.718 |
Low: | $2.45 |
Volume: | 1,088,528 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Emergent Biosolutions Inc. (NYSE:EBS)
As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN ® Nasal Spray and build on its longstanding efforts with public interest entities across the country Hundreds of thousands...
2024-03-25 08:54:44 ET More on Emergent Biosolutions Emergent BioSolutions Inc. (EBS) Q4 2023 Earnings Call Transcript Emergent BioSolutions Inc. 2023 Q4 - Results - Earnings Call Presentation New CEO Appointment A Clear Positive For Emergent BioSolutions Ben...
Message Board Posts | Emergent Biosolutions Inc. (NYSE:EBS)
Subject | By | Source | When |
---|---|---|---|
Lets go go go go... Up up and away we go. | GM26 | investorshub | 05/08/2023 11:17:23 PM |
Price gaining last up | TREND1 | investorshub | 05/07/2023 7:05:19 PM |
$EBS short squeeze | mick | investorshub | 05/07/2023 5:51:59 PM |
$EBS When is this gonna take off? | mick | investorshub | 05/06/2023 6:06:33 AM |
$EBS short squeeze article | TREND1 | investorshub | 05/05/2023 10:45:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN ® Nasal Spray and build on its longstanding efforts with public interest entities across the country Hundreds of thousands...
GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has listed “No Action Indicated” or NAI status classification for the company's Baltimore Bayview manufacturing facility. Base...
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-q...